This bill removes the legal provision that set a termination date for the Louisiana Behavior Analyst Board, allowing the regulatory body to continue operating. By repealing the specific statute that established the board's expiration, the legislation ensures the board remains active for overseeing behavior analysts in the state. The change directly affects the board's ability to regulate professionals and maintain oversight without a fixed end date. No new powers or requirements are added; the bill simply eliminates the existing deadline for the board's existence.
This bill requires health insurance companies in Louisiana to cover mobile crisis response and behavioral health crisis care services when provided by eligible licensed providers. The law mandates that these services do not need prior authorization from insurers and allows providers to coordinate with the state's Crisis Hub for information sharing. Coverage may include standard cost-sharing options like deductibles and copayments, while reimbursement methods remain up to each insurer's discretion. The bill defines these services as short-term, recovery-focused interventions for adults and children experiencing mental health or substance use crises, with an effective date of July 1, 2027.
HB 807 establishes a special fund within Louisiana's state treasury to support the Community and Technical College System's workforce training programs. It directly affects community colleges and private-sector employers in high-demand industries like healthcare, manufacturing, and information technology by providing funding to hire more instructors and expand training capacity. Key provisions include using the fund for rapid-response instructor deployment, recruitment incentives, temporary instructors, and salary supplements - while prohibiting these funds from replacing existing state higher education funding. The program requires annual reporting to legislative committees on fund usage, supported industries, and credentials awarded.
HB 761 creates an advisory board within Louisiana's Department of Health to review and recommend new treatments for rare cancers. The 17-member board includes health officials, cancer researchers, oncologists from major institutions (like LSU, Tulane, and Xavier), and representatives from cancer research centers. The board must hold quarterly public meetings, compile findings within 30-45 days, and submit written reports to the Insurance Committees of both legislative chambers. This process directly affects how the Department of Health evaluates rare cancer treatments, streamlining recommendations to the agency for potential adoption.
HB 291 prevents health insurers in Louisiana from penalizing hospitals or clinics (participating healthcare facilities) solely because another provider at that facility - like a doctor or specialist - is dropped from the insurer's network. The bill directly affects healthcare facilities that coordinate patient care with multiple providers, ensuring they won’t face payment cuts or contract terminations due to a partner provider’s network status. Key provisions ban insurers from reducing payments or ending agreements with facilities based on another provider’s network exclusion, and require that any contract clauses attempting to override this rule are void. This policy change aims to stabilize provider relationships and care continuity for patients.
HB 823 establishes a pilot program in Orleans Parish that offers homeless individuals facing criminal charges an alternative to court proceedings. Instead of traditional sentencing, eligible defendants can participate in a diversion program providing housing assistance, mental health services, job training, and substance abuse treatment. If participants successfully complete the program’s requirements, the criminal charges are dismissed without a conviction. The program requires annual evaluations and reporting to the Louisiana Supreme Court, aiming to reduce recidivism, court workload, and prison overcrowding while addressing homelessness through community partnerships.
HB 766 requires health insurers in Louisiana to cover orally administered anti-cancer medications on the same terms as intravenously administered ones. It prohibits insurers from imposing higher copays, deductibles, or prior authorizations for oral medications compared to IV treatments, and bans programs that ignore drug discounts (like "accumulator" programs). The bill caps out-of-pocket costs for oral anti-cancer drugs at $100 per prescription and ensures cost-sharing counts toward annual out-of-pocket maximums. It applies to most health plans but excludes limited-benefit policies, high-deductible plans with HSAs, and self-funded ERISA plans. This directly affects cancer patients and insurers by reducing financial barriers to oral medication access.
This bill directs the United States Congress to collaborate on finding a cure for Sanfilippo Syndrome, a rare genetic disorder affecting children. The resolution calls for legislative action and support rather than establishing new funding or regulatory requirements. It was recently passed by the House of Representatives with unanimous support. The primary effect is a formal statement of intent to address this specific medical condition.
This resolution asks the Louisiana Commission on Law Enforcement and Administration of Criminal Justice to study how forensic medical exams for domestic violence survivors are currently handled across the state. The goal is to create consistent rules for these exams so that victims in rural areas receive the same care and evidence collection standards as those in cities. The commission will also look into making the payment process for these specialized medical services clearer and more reliable. To help with this study, the commission is invited to gather input from various groups, including hospitals, law enforcement agencies, and domestic violence advocates. Finally, the commission must submit its findings and suggestions to the legislature by June 2027.
This Louisiana House resolution asks various medical and coding organizations to review and update terms used to describe miscarriage and pregnancy loss. The bill specifically urges groups like the World Health Organization and the American Medical Association to replace older phrases such as "spontaneous abortion" with language that is more compassionate and less likely to cause confusion or emotional distress. By recommending terms like "early pregnancy loss" or "miscarriage," the resolution aims to ensure that clinical records and billing documents reflect patient preferences while maintaining medical accuracy. This request is based on findings that current terminology can stigmatize women and negatively impact their mental health during a traumatic time.